Trial analysis by PHS investigators reveals supplement hazard in largest-ever prostate cancer prevention study
Nov. 21, 2011
Men who took 400 international units of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT). The Fred Hutchinson Cancer Research Center Public Health Sciences Division's Phyllis Goodman and Drs. Cathy Tangen and Gary Goodman (whose primary appointment is at the Swedish Cancer Institute) analyzed the data for this study.